P008 What's Hot in Pediatric Dermatology
DESCRIPTION
There have been many exciting recent developments in pediatric dermatology. This session will focus on emerging trends and advances in inflammatory, infectious, and neoplastic skin conditions that affect children, with emphasis on diagnostic and treatment strategies including the use of systemic therapies. Updates on vascular anomalies, atopic dermatitis, and severe cutaneous adverse reactions in pediatric patients will be provided, and the use of sunscreen in children and adolescents will be addressed.
LEARNING OBJECTIVES
Recognize etiologic factors and clinical manifestations of inflammatory, infectious, and neoplastic disorders in pediatric patients and use these observations to formulate state-of-the art management strategies
Utilize recent advances to evaluate and treat atopic dermatitis, severe cutaneous adverse reactions, and vascular anomalies in pediatric patients
Provide updated recommendations for sun protection in children and adolescents
SCHEDULE
8:00 PM
Introduction
Julie V. Schaffer, MD, FAAD
8:05 PM
Hot Topics in Sun Protection for Children and Adolescents
Latanya Benjamin, MD, FAAD
8:35 PM
Q & A
Latanya Benjamin, MD, FAAD
8:40 PM
What’s Hot in Hemangiomas and Vascular Anomalies
Esteban Fernandez Faith, MD, FAAD
9:10 PM
Q & A
Esteban Fernandez Faith, MD, FAAD
9:15 PM
Update on Atopic Dermatitis in Pediatric Patients
Thy Nhat Huynh, MD, FAAD
9:45 PM
Q & A
Thy Nhat Huynh, MD, FAAD
9:50 PM
Pediatric Dermatology Challenges: What's New and What's True
Julie V. Schaffer, MD, FAAD
10:20 PM
Q & A
Julie V. Schaffer, MD, FAAD
10:25 PM
Severe Cutaneous Adverse Reactions: Current Concepts and Advances
Michele Ramien, MD, FAAD
10:55 PM
Q & A
Michele Ramien, MD, FAAD
SPEAKERS
Latanya Benjamin, MD, FAAD
Esteban Fernandez Faith, MD, FAAD
Thy Nhat Huynh, MD, FAAD
Michele Ramien, MD, FAAD
Alberta Children's Hospital, University of Calgary
Julie V. Schaffer, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Latanya Benjamin, MD, FAAD
No financial relationships exist with ineligible companies.
Esteban Fernandez Faith, MD, FAAD
Pierre Fabre – Speaker(Honoraria);
Thy Nhat Huynh, MD, FAAD
No financial relationships exist with ineligible companies.
Michele Ramien, MD, FAAD
Eli Lilly – Consultant (1099 relationship)(Honoraria); Leo Pharma Inc – Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding), Speaker(Honoraria);
Julie V. Schaffer, MD, FAAD
American Board of Dermatology – Employee(Salary); Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);